
Biocure Technology Inc. — Investor Relations & Filings
Biocure Technology Inc. is a biopharmaceutical company specializing in the development and commercialization of advanced biological medicines. The company's core focus areas include proprietary CAR T-cell therapies designed to treat various cancers, such as leukemia, lung, and breast cancer. Concurrently, Biocure is engaged in the development and commercialization of major biosimilar pharmaceutical products, aiming to improve the accessibility of complex biological treatments. Furthermore, the company pursues novel, highly-efficacious therapies for severe diseases caused by RNA viruses where significant unmet medical needs exist.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2026-05-13 | English | |
| ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF | 2026-04-15 | English | |
| AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF | 2026-04-15 | English | |
| ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF | 2026-04-15 | English | |
| AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF | 2026-04-15 | English | |
| 52-109FV1 - Certification of annual filings - CEO (E).pdf | 2026-04-15 | English |
Browse filings by year
19 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Moberg Pharma
Pharmaceutical company developing and commercializing treat…
|
MOB | SE | Manufacturing |
|
Mochida Pharmaceutical Co.,Ltd.
Develops and sells pharmaceuticals, healthcare products, an…
|
4534 | JP | Manufacturing |
|
Modalis Therapeutics Corporation
Develops genetic medicines using a proprietary epigenome ed…
|
4883 | JP | Manufacturing |
|
Moderna, Inc.
Biotechnology company developing messenger RNA (mRNA) thera…
|
MRNA | US | Manufacturing |
|
Modern Chinese Medicine Group Co., Ltd.
Produces and sells proprietary modern Chinese medicines, sp…
|
1643 | HK | Manufacturing |
|
Molecular Partners AG
Clinical-stage company developing novel protein therapeutic…
|
MOLN | CH | Manufacturing |
|
Moleculin Biotech, Inc.
A late-stage pharmaceutical company developing drugs for re…
|
MBRX | US | Manufacturing |
|
Monte Rosa Therapeutics, Inc.
Develops molecular glue degraders to eliminate disease-caus…
|
GLUE | US | Manufacturing |
|
Moogene Medi Co., Ltd.
Develops nanomedicine-based drug delivery systems for treat…
|
322970 | KR | Manufacturing |
|
MoonLake Immunotherapeutics
Clinical-stage biopharma developing Nanobody therapies for …
|
MLTX | US | Manufacturing |
Biocure Technology Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46211/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46211 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46211 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46211 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46211}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biocure Technology Inc. (id: 46211)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.